{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/de028606-3c1d-46b6-916d-c88c9276b101?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"10x Genomics’ Serge Saxonov: \"Never has so much brainpower been focussed on one problem\"","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/61ba0b4a40076a0012722c78.jpg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Serge Saxonov, founder of 10x Genomics, to talk about the end of normalcy (3:00), his high-end espresso machine for biology (4:20), delivering on the promise of genomics (6:20), how 10x is contributing to the coronavirus vaccine race (8:00), why a vaccine is theoretically achievable (10:15), the global shift to Covid research (13:15), leaving the Soviet Union and landing in New York (15:30), starting 23andMe (19:20), starting 10x (22:00), why it was hard to raise money (23:25), luring Softbank as an investor (25:55), 10x's footprint (26:50), the importance of resolution (28:10), and his worst day of work (32:00)</p>","author_name":"The Sunday Times"}